1g3x: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "1g3x" [edit=sysop:move=sysop] |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==INTERCALATION OF AN 9ACRIDINE-PEPTIDE DRUG IN A DNA DODECAMER== | |||
<StructureSection load='1g3x' size='340' side='right'caption='[[1g3x]], [[Resolution|resolution]] 2.70Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[1g3x]] is a 13 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G3X OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1G3X FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.7Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9AC:9-ACRIDINECARBONYL'>9AC</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1g3x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1g3x OCA], [https://pdbe.org/1g3x PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1g3x RCSB], [https://www.ebi.ac.uk/pdbsum/1g3x PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1g3x ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
We present the crystal structure of an acridine drug derivatized at carbon 9, [N(alpha)-(9-acridinoyl)-tetraarginine], intercalated within the dodecamer [d(CGCGAATTCGCG)](2). The presence of a lateral chain at the central carbon 9 atom differentiates this compound from most acridine drugs hitherto studied, which are usually derivatized at carbon 4. The DNA:drug interaction we observe differs from that observed in previous studies, which primarily involves shorter, mainly hexameric sequences, in two important regards: the acridine intercalates within an AA/TT base step, rather than within a CG/CG base step; and the binding site is located at the center of the sequence, rather than at one end of the duplex. In addition, we observe a novel crystal packing arrangement, with six dodecamer duplexes and seven hydrated magnesium ions in the asymmetric unit of a large (66.5 x 68.4 x 77.4 A(3)) unit cell in space group P2(1)2(1)2(1). The duplexes are organized in layers parallel to the ab plane, with consecutive layers crossing each other at right angles. | |||
Intercalation of an acridine-peptide drug in an AA/TT base step in the crystal structure of [d(CGCGAATTCGCG)](2) with six duplexes and seven Mg(2+) ions in the asymmetric unit.,Malinina L, Soler-Lopez M, Aymami J, Subirana JA Biochemistry. 2002 Jul 30;41(30):9341-8. PMID:12135355<ref>PMID:12135355</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
== | <div class="pdbe-citations 1g3x" style="background-color:#fffaf0;"></div> | ||
[[ | == References == | ||
[[Category: Aymami | <references/> | ||
[[Category: Malinina | __TOC__ | ||
[[Category: Soler-Lopez | </StructureSection> | ||
[[Category: Subirana | [[Category: Large Structures]] | ||
[[Category: Aymami J]] | |||
[[Category: Malinina L]] | |||
[[Category: Soler-Lopez M]] | |||
[[Category: Subirana JA]] | |||